Navigation Links
Cell Biosciences Launches Next-Generation Protein Characterization System

PALO ALTO, Calif., April 16 /PRNewswire/ -- Cell Biosciences, Inc., a provider of nanoproteomic analysis systems to life science researchers, today announced the launch of the Cell Biosciences CB1000 protein analysis system, a next-generation platform for ultrasensitive characterization of cell signaling proteins. The CB1000 establishes a new standard for sensitivity, reproducibility, and ease-of-use for researchers studying signaling pathways in limited samples, such as small tumor biopsies and stem cells. The CB1000 will be unveiled at the American Association for Cancer Research (AACR) 100th Annual Meeting, April 18-22, 2009, in Denver, Colorado (booth 2039).

The CB1000 system measures phosphorylation events and other protein post-translational modifications using capillary-based nanofluidic immunoassays, and builds upon the fundamental technology of its predecessor, the Firefly(TM) 3000 system. The advanced design of the CB1000 system provides significant improvements in assay performance and automation, including a doubling of sample throughput. Assay reproducibility and stability have been increased through the incorporation of precise temperature control systems. In addition, the CB1000's software package, Compass(TM), features dramatic improvements in data analysis speed.

David Hirschberg, Ph.D., Director of the Human Immune Monitoring Center at Stanford University School of Medicine, recently completed a three-month evaluation of a prototype CB1000 system. "This system represents an impressive step forward for Cell Biosciences' technology," noted Dr. Hirschberg. "My group has been using the CB1000 system heavily - typically six days a week. We have been extremely pleased by the system's high level of performance and reliability."

"The CB1000 is our first platform designed for broad distribution," added Tim Harkness, President and Chief Executive Officer at Cell Biosciences. "We believe that the CB1000 will allow us to penetrate important new markets as we build our worldwide commercial infrastructure. We also believe that the CB1000 will enable our customers to gain novel insights into the causes and treatment of human disease."

About Cell Biosciences

Cell Biosciences is a private life sciences company focused on nanoproteomics. We develop instrumentation systems, software, and assay products that reveal previously undetectable information about cellular control pathways. Our customers include leading institutions in the fields of cancer research, stem cell biology, and diabetes. Our products enable researchers to uncover fundamental mechanisms controlling cell proliferation and cell death, to accelerate the development of new therapeutics, and to help identify new prognostic and diagnostic disease biomarkers. Cell Biosciences is located in Palo Alto, California. For more information, visit

SOURCE Cell Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cell Biosciences Announces Publication in Nature Medicine
2. Cell Biosciences Closes $10 Million Series C Financing
3. SAFC Biosciences(R) Expands Media Capability for Chinese Hamster Ovary (CHO) Cell Lines
4. SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free
5. Neurocrine Biosciences to Present at the 16th Annual Future Leaders in the Biotech Industry Conference
6. Catalyst Biosciences Expands Scientific Advisory Board With Leading Experts in Protease Therapeutic Discovery and Development
7. WaferGen Biosystems, ImmuneRegen BioSciences and University of Texas Southwestern Medical Center to Collaborate on Novel Wound Healing Research
8. Neurocrine Biosciences to Present at the Cowen and Company 29th Annual Health Care Conference
9. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
10. Pressure BioSciences, Inc. to Present at the EdgeWater Research Partners Spring 2009 Micro/Small-Cap Investor Conference
11. Speid & Associates Partners With Genizon BioSciences to Reduce Attrition Rates of New Drug Compounds
Post Your Comments:
(Date:6/23/2016)... ... 2016 , ... Mosio, a leader in clinical research patient ... and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the hurdle ... and strategies for clinical researchers. , “The landscape of how patients receive and ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
Breaking Biology Technology:
(Date:6/2/2016)... 2, 2016 The Department of Transport ... the 44 million US Dollar project, for the , ... including Personalization, Enrolment, and IT Infrastructure , to ... production and implementation of Identity Management Solutions. Numerous renowned international ... Decatur was selected for the most compliant ...
(Date:6/2/2016)... , June 2, 2016 Perimeter ... Platforms, Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... market will generate revenues of $17.98 billion in 2016. ... DVTEL Inc, a leader in software and hardware technologies ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):